1-3 of 3
Daniel E Fein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents.

Raymond L. Comenzo, MD, Daniel E Fein, Hani Hassoun, MD, Christina Bello, Joanne F Chou, Sean Devlin, PhD, Sergio A Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2012) 120 (21): 3150.
https://doi.org/10.1182/blood.V120.21.3150.3150
Published: 2012
Journal Articles

Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience.

Heather Landau, MD, Daniel E Fein, Hani Hassoun, MD, Christina Bello, Joanne F Chou, Sean Devlin, PhD, Sergio Giralt, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2012) 120 (21): 3109.
https://doi.org/10.1182/blood.V120.21.3109.3109
Published: 2012
Journal Articles

Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma

Daniel E Fein, Hani Hassoun, MD, Raymond L. Comenzo, MD, Alex Lesokhin, Nikoletta Lendvai, MD, PhD, David Chung, MD, PhD, Adam Cohen, Michael A. Rosenzweig, MD, Danielle Chimento, Xiaoyu Jia, Stephen Nimer, Sergio Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2010) 116 (21): 1353.
https://doi.org/10.1182/blood.V116.21.1353.1353
Published: 2010